SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Discusses AI Infrastructure Partnership and Major Data Center Lease with Anthropic and Fluidstack December 17, 2025 12:00 PM ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...

The Trump administration on Tuesday imposed visa bans on a former European Union commissioner and anti-disinformation campaigners it says were involved in censoring U.S. social media platforms, in the ...

The only thing more frustrating than someone trying to patronize you is when someone tries to talk down to you about a ...